Advertisement

Topics

Romosozumab reduced vertebral fracture risk in older women with osteoporosis

14:22 EDT 14 Jun 2017 | Healio

MADRID — Treatment with a novel sclerostin inhibitor, romosozumab, was associated with a reduced rate of vertebral fractures at 12 months compared with placebo in a cohort of post-menopausal women with osteoporosis, according to findings presented at the Annual European Congress of Rheumatology.Piet Geusens, MD, PhD, of Maastricht UMC in Maastricht, Netherlands and UHasselt and ReumaClinic in Genk, Belgium, noted that romosozumab (UCB & Amgen) has the dual effect of increasing bone formation and reducing bone resorption.

Original Article: Romosozumab reduced vertebral fracture risk in older women with osteoporosis

NEXT ARTICLE

More From BioPortfolio on "Romosozumab reduced vertebral fracture risk in older women with osteoporosis"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...